122 related articles for article (PubMed ID: 1713845)
1. In vivo somatic mutation in the lymphocytes of Hodgkin's disease patients.
Caggana M; Liber HL; Mauch PM; Coleman CN; Kelsey KT
Environ Mol Mutagen; 1991; 18(1):6-13. PubMed ID: 1713845
[TBL] [Abstract][Full Text] [Related]
2. [Radiotherapy of Hodgkin's disease].
PatrÃcio MB
Acta Med Port; 1990; 3(1):11-3. PubMed ID: 1692179
[TBL] [Abstract][Full Text] [Related]
3. Conventional salvage therapy for Hodgkin's lymphoma.
Pfreundschuh M; Schaadt M; Diehl V
Recent Results Cancer Res; 1989; 117():225-32. PubMed ID: 2481331
[No Abstract] [Full Text] [Related]
4. [Controversy regarding the treatment of Hodgkin's disease].
Balwierz W; Armata J
Pol Tyg Lek; 1989 Apr; 44(14):315-9. PubMed ID: 2482966
[No Abstract] [Full Text] [Related]
5. [Advances in the chemotherapy of malignant lymphoma 1. Chemotherapy of Hodgkin's disease].
Suon SZ
Zhonghua Nei Ke Za Zhi; 1985 Feb; 24(2):117-120, contd. PubMed ID: 2580675
[No Abstract] [Full Text] [Related]
6. The case against the routine use of radiation therapy in advanced-stage Hodgkin's disease.
Longo DL
Cancer Invest; 1996; 14(4):353-60. PubMed ID: 8689431
[No Abstract] [Full Text] [Related]
7. Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data.
Prosnitz LR; Farber LR; Kapp DS; Scott J; Bertino JR; Fischer JJ; Cadman EC
J Clin Oncol; 1988 Apr; 6(4):603-12. PubMed ID: 2451712
[TBL] [Abstract][Full Text] [Related]
8. Combined chemotherapy-radiotherapy in advanced Hodgkin's disease: results of a prospective clinical trial with 70 stage IIIB-IV patients.
Fermé C; Lepage E; Brice P; D'Agay MF; Fermand JP; Castaigne S; Frija J; Miot C; Marty M; Gisselbrecht C
Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):397-405. PubMed ID: 7685749
[TBL] [Abstract][Full Text] [Related]
9. [Controversial aspects in the current treatment of Hodgkin's disease].
Vicente J
Rev Clin Esp; 1987 Feb; 180(3):158-64. PubMed ID: 2437622
[No Abstract] [Full Text] [Related]
10. Results and prognostic factors following optimal treatment of advanced Hodgkin's disease.
Straus DJ; Gaynor J; Myers J; Merke D; Chapman D; Caravelli J; Nisce LZ; Lee BJ; Clarkson BD
Recent Results Cancer Res; 1989; 117():191-6. PubMed ID: 2481329
[No Abstract] [Full Text] [Related]
11. Laparotomy and splenectomy in Hodgkin's disease: a reappraisal after twenty years.
Rosenberg SA
Scand J Haematol; 1985 Apr; 34(4):289-92. PubMed ID: 2408324
[No Abstract] [Full Text] [Related]
12. Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
Vassilakopoulos TP; Angelopoulou MK; Siakantaris MP; Kontopidou FN; Dimopoulou MN; Kokoris SI; Kyrtsonis MC; Tsaftaridis P; Karkantaris C; Anargyrou K; Boutsis DE; Variamis E; Michalopoulos T; Boussiotis VA; Panayiotidis P; Papavassiliou C; Pangalis GA
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):765-81. PubMed ID: 15183480
[TBL] [Abstract][Full Text] [Related]
13. [The combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP) before radiotherapy in localized stages of Hodgkin's disease. Phase II trials].
Zittoun R; Eghbali H; Audebert A; Rojouan J; David B; Blanc CM; Hoerni B; Debray J
Bull Cancer; 1987; 74(2):151-7. PubMed ID: 2440504
[TBL] [Abstract][Full Text] [Related]
14. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
Canellos GP
Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
[TBL] [Abstract][Full Text] [Related]
15. [Improved survival rates in Hodgkin's disease].
Hayabuchi N; Jingu K; Miyoshi M; Hirata H; Masuda K; Shibuya T; Nishimura J; Komiyama S; Ishii E; Kikuchi M
Gan No Rinsho; 1988 Apr; 34(5):698-704. PubMed ID: 2455073
[TBL] [Abstract][Full Text] [Related]
16. MOPP versus ABVD and low-dose versus high-dose irradiation in Hodgkin's disease at intermediate and advanced stages: analysis of a meta-analysis by clinicians.
Andrieu JM; Yilmaz U; Colonna P
J Clin Oncol; 1999 Feb; 17(2):730-4. PubMed ID: 10080622
[No Abstract] [Full Text] [Related]
17. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT
J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
[TBL] [Abstract][Full Text] [Related]
18. Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
Sieber M; Tesch H; Pfistner B; Rueffer U; Lathan B; Brosteanu O; Paulus U; Koch T; Pfreundschuh M; Loeffler M; Engert A; Josting A; Wolf J; Hasenclever D; Franklin J; Duehmke E; Georgii A; Schalk KP; Kirchner H; Doelken G; Munker R; Koch P; Herrmann R; Greil R; Anselmo AP; Diehl V
J Clin Oncol; 2002 Jan; 20(2):476-84. PubMed ID: 11786577
[TBL] [Abstract][Full Text] [Related]
19. Clinical investigations of children with Hodgkin's disease at Stanford University Medical Center. A preliminary overview using low-dose irradiation and alternating ABVD/MOPP chemotherapy.
Donaldson SS; Link MP; McDougall IR; Parker BR; Shochat SJ
Cancer Treat Res; 1989; 41():307-15. PubMed ID: 2484294
[No Abstract] [Full Text] [Related]
20. Sister chromatid exchange frequency in Hodgkin's disease patients with elevated in vivo hprt mutant frequencies.
Caggana M; Kelsey KT
Carcinogenesis; 1991 Nov; 12(11):2141-5. PubMed ID: 1934301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]